XML 42 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Fair Values of Stock Option Grants Estimated with Weighted Average Assumptions

The fair values of our stock option grants were estimated with the following weighted average assumptions:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Expected life

 

5.2 years

 

 

3.3 years

 

 

5.3 years

 

 

3.3 years

 

Expected volatility

 

 

55

%

 

 

52

%

 

 

54

%

 

 

53

%

Risk-free interest rate

 

 

2.7

%

 

 

1.6

%

 

 

2.5

%

 

 

1.7

%

 

Stock-Based Compensation Expense

 

The impact on our results of operations from stock-based compensation expense was as follows (in thousands, except per share amounts):  

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Cost of revenue — professional engineering service

$

8

 

 

$

20

 

 

$

19

 

 

$

85

 

Selling, general and administrative

 

(80

)

 

 

320

 

 

 

184

 

 

 

604

 

Research and development

 

56

 

 

 

71

 

 

 

112

 

 

 

121

 

Total stock-based compensation expense

$

(16

)

 

$

411

 

 

$

315

 

 

$

810

 

Per diluted share

$

(0.00

)

 

$

0.03

 

 

$

0.02

 

 

$

0.06

 

 

Summary of Stock Option Activity

The following table summarizes stock option activity under the Plans:

 

 

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

Contractual Life

 

 

Aggregate

 

 

 

Number of Shares

 

 

Exercise Price

 

 

(in years)

 

 

Intrinsic Value

 

Balance at December 31, 2017

 

 

1,912,161

 

 

$

4.88

 

 

 

7.61

 

 

$

781,735

 

Granted

 

 

256,643

 

 

 

3.95

 

 

 

 

 

 

 

 

 

Exercised

 

 

(2,422

)

 

 

3.59

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(265,697

)

 

 

4.90

 

 

 

 

 

 

 

 

 

Expired

 

 

(22,605

)

 

 

5.72

 

 

 

 

 

 

 

 

 

Balance at June 30, 2018

 

 

1,878,080

 

 

$

4.74

 

 

 

6.28

 

 

$

5,080

 

Vested and expected to vest at June 30, 2018

 

 

1,784,268

 

 

$

4.73

 

 

 

6.14

 

 

$

5,080

 

Exercisable at June 30, 2018

 

 

1,181,163

 

 

$

4.60

 

 

 

4.80

 

 

$

5,080

 

 

Summary of Certain Additional Information about Stock Options

The following table summarizes certain information about stock options:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Weighted average grant-date fair value of options granted during the period

 

$

1.77

 

 

$

2.64

 

 

$

1.98

 

 

$

2.80

 

Options in-the-money (in shares)

 

 

19,550

 

 

 

1,755,762

 

 

 

19,550

 

 

 

1,755,762

 

Aggregate intrinsic value of options exercised during the period

 

$

1,578

 

 

$

17,412

 

 

$

1,853

 

 

$

57,833

 

 

Summary of Restricted Stock Unit Activity

The following table summarizes RSU activity under the Plans:

 

 

 

Number of

 

 

Weighted Average

 

 

 

Shares

 

 

Award Price

 

Unvested at December 31, 2017

 

 

116,968

 

 

$

5.33

 

Granted

 

 

136,505

 

 

 

3.21

 

Vested

 

 

(46,764

)

 

 

5.14

 

Forfeited

 

 

(26,312

)

 

 

5.31

 

Unvested at June 30, 2018

 

 

180,397

 

 

$

3.78

 

Expected to vest after June 30, 2018

 

 

165,730

 

 

$

3.75

 

 

Summary of Shares of Common Stock Reserved for Future Issuance under Plans

The following table summarizes our shares of common stock reserved for future issuance under the Plans as of June 30, 2018:

 

 

 

June 30, 2018

 

Stock options outstanding

 

 

1,878,080

 

Restricted stock units outstanding

 

 

180,397

 

Stock options available for future grant

 

 

1,110,722

 

Common stock reserved for future issuance

 

 

3,169,199